Figure 1.

Selected Computed Tomography (CT) Imaging at Clinically Important Timepoints. a) CT at time of diagnosis showing 5 cm distal pancreatic mass. b) CT following four months of adjuvant gemcitabine/capecitabine demonstrating a 1 cm segment V liver metastasis c) CT following three months of FOLFIRINOX showing complete radiographic response of segment V liver metastasis. d) CT two years following metastasectomy demonstrating a 4 cm caudate lobe recurrence